GlassScriptPhysician profile
Shaheen Mohsin
NPI 1033111489
$2,346.93
in general payments reported to CMS, 2019-2025
19 companies · $721 in 2025
The $721 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $145 · 2021: $65.29 · 2022: $211 · 2023: $462 · 2024: $313 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $792.87 | 2019-2024 | Jornay Pm |
| Corium, LLC | $287.93 | 2021-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $253.54 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $153.74 | 2025 | Neffy |
| Cranial Technologies, INC | $135.60 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $129.01 | 2024-2025 | |
| Tris Pharma INC | $128.61 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Merck Sharp & Dohme LLC | $99.67 | 2019-2021 | |
| Kaleo, INC. | $94.78 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $64.00 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.18 | 2020-2021 | |
| Shire North American Group INC | $33.07 | 2019 | |
| Neos Therapeutics, LP | $32.20 | 2019-2020 | |
| Phadia US INC. | $24.19 | 2025 | Immunocap |
| Lnhc, INC | $17.38 | 2025 | Zelsuvmi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $15.64 | 2023 | |
| Vertical Pharmaceuticals, LLC | $14.71 | 2025 | Relexxii |
| Supernus Pharmaceuticals, INC. | $14.56 | 2023 | Qelbree |
| Genentech USA, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaheen Mohsin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.